 Critical analysis neoadjuvant therapy Stage IIIa non-small cell lung cancer erratum Am Rev Respir Dis Jun Lung cancer major cause cancer mortality advanced Stage III disease entire group non-small cell lung cancer NSCLC Surgical resection opportunity cure resection disease possible minority patients Stage IIIa disease patients successful surgery systemic relapse common survival complete resection Preoperative neoadjuvant chemotherapy investigation attempt bleak outcome patients Stage IIIa NSCLC Preliminary trials approach feasible neoadjuvant treatment moderate toxicity cases possibility surgical resection instances neoadjuvant treatment pathologic complete responses others tumor bulk inoperable patients surgical candidates latter phenomenon impact survival unknown role neoadjuvant treatment advanced lung cancer trials